{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:17:31Z","timestamp":1779279451179,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jasc.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:27:05Z","timestamp":1772641625000},"page":"197-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytomorphologic and molecular characterization of metastatic renal cell carcinoma diagnosed by fine-needle biopsy: a single-institution study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-9842","authenticated-orcid":false,"given":"Matthew L.","family":"Kleinjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0455-9413","authenticated-orcid":false,"given":"Tatjana","family":"Antic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2026.02.003_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: A review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2026.02.003_bib2","first-page":"229","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2026.02.003_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/UA.UA_102_17","article-title":"Epidemiology profile of renal cell carcinoma: A 10-year patients' experience at king abdulaziz medical city, national guard health affairs, saudi arabia","volume":"10","author":"Mahasin","year":"2018","journal-title":"Urol Ann"},{"key":"10.1016\/j.jasc.2026.02.003_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-4598-13-39","article-title":"Molecular subtyping of metastatic renal cell carcinoma: Implications for targeted therapy","volume":"13","author":"Wang","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jasc.2026.02.003_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2008.09.009","article-title":"Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms","volume":"40","author":"Cheng","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jasc.2026.02.003_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jasc.2026.02.003_bib8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1148\/rg.2021200206","article-title":"Chromophobe renal cell carcinoma with radiologic-pathologic correlation","volume":"41","author":"Marko","year":"2021","journal-title":"Radiographics"},{"key":"10.1016\/j.jasc.2026.02.003_bib9","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/j.celrep.2018.06.032","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jasc.2026.02.003_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1442-2042.2009.02302.x","article-title":"2009 update on the classification of renal epithelial tumors in adults","volume":"16","author":"Lopez-Beltran","year":"2009","journal-title":"Int J Urol"},{"key":"10.1016\/j.jasc.2026.02.003_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and male genital organs-part a: Renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.jasc.2026.02.003_bib12","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2026.02.003_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97365-6","article-title":"The prognosis and clinicopathological features of different distant metastases patterns in renal cell carcinoma: Analysis based on the seer database","volume":"11","author":"Wei","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jasc.2026.02.003_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.21869","article-title":"Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival","volume":"4","author":"Dudani","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jasc.2026.02.003_bib15","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e293","article-title":"Sites of metastasis and survival in metastatic renal cell carcinoma: Results from the korean renal cancer study group database","volume":"39","author":"Lee","year":"2024","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jasc.2026.02.003_bib16","doi-asserted-by":"crossref","first-page":"661.e667","DOI":"10.1016\/j.urolonc.2017.06.060","article-title":"Metastatic renal cell carcinoma: Patterns and predictors of metastases-a contemporary population-based series","volume":"35","author":"Chandrasekar","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2026.02.003_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: A population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jasc.2026.02.003_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/1752-1947-5-429","article-title":"Atypical presentations and rare metastatic sites of renal cell carcinoma: A review of case reports","volume":"5","author":"Sountoulides","year":"2011","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jasc.2026.02.003_bib19","doi-asserted-by":"crossref","first-page":"E553","DOI":"10.1111\/j.1464-410X.2012.11246.x","article-title":"Late recurrence of renal cell carcinoma >5 years after surgery: Clinicopathological characteristics and prognosis","volume":"110","author":"Park","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2026.02.003_bib20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/cncr.11234","article-title":"Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: A stratification tool for prospective clinical trials","volume":"97","author":"Leibovich","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jasc.2026.02.003_bib21","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.2147\/OTT.S171881","article-title":"Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma","volume":"11","author":"Zhang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jasc.2026.02.003_bib22","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2002.11.123","article-title":"Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology","volume":"20","author":"Motzer","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jasc.2026.02.003_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016309","article-title":"A comparison of the prognosis of papillary and clear cell renal cell carcinoma: Evidence from a meta-analysis","volume":"98","author":"Deng","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jasc.2026.02.003_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eururo.2012.05.009","article-title":"Rationale for percutaneous biopsy and histologic characterisation of renal tumours","volume":"62","author":"Volpe","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jasc.2026.02.003_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41585-024-00897-5","article-title":"Renal mass biopsy - a practical and clinicopathologically relevant approach to diagnosis","volume":"22","author":"Mansour","year":"2025","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jasc.2026.02.003_bib26","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.5858\/arpa.2018-0463-RA","article-title":"Needle biopsy adequacy in the era of precision medicine and value-based health care","volume":"143","author":"Pritzker","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2026.02.003_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000513065","article-title":"Accuracy of subclassification and grading of renal tumors on fine needle aspiration cytology alone","volume":"65","author":"Chen","year":"2021","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2026.02.003_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/dc.25147","article-title":"Rapid on-site evaluation in percutaneous core needle biopsies of renal masses: Cytologic-histologic concordance and diagnostic challenges","volume":"51","author":"Hojat","year":"2023","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/1742-6413.192191","article-title":"Endoscopic ultrasound-guided fine needle aspiration cytology of metastatic renal cell carcinoma to the pancreas: A multi-center experience","volume":"13","author":"Pannala","year":"2016","journal-title":"Cytojournal"},{"key":"10.1016\/j.jasc.2026.02.003_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.14366\/usg.16037","article-title":"Metastatic renal cell carcinoma in the thyroid gland: Ultrasonographic features and the diagnostic role of core needle biopsy","volume":"36","author":"Song","year":"2017","journal-title":"Ultrasonography"},{"key":"10.1016\/j.jasc.2026.02.003_bib31","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.5858\/arpa.2014-0283-CC","article-title":"Diagnosis of metastatic renal cell carcinoma on fine-needle aspiration cytology","volume":"138","author":"Lew","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2026.02.003_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176230","article-title":"Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma","volume":"134","author":"Gulati","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jasc.2026.02.003_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays","volume":"19","author":"Kadri","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jasc.2026.02.003_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/PAS.0000000000000835","article-title":"Rbm10-tfe3 renal cell carcinoma: A potential diagnostic pitfall due to cryptic intrachromosomal xp11.2 inversion resulting in false-negative tfe3 fish","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/KCA-160002","article-title":"Outcomes of metastatic chromophobe renal cell carcinoma (chrrcc) in the targeted therapy era: Results from the international metastatic renal cell cancer database consortium (imdc)","volume":"1","author":"Yip","year":"2017","journal-title":"Kidney Cancer"},{"key":"10.1016\/j.jasc.2026.02.003_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188823","article-title":"Mit translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical management","volume":"1877","author":"Rizzo","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jasc.2026.02.003_bib37","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.3390\/ijms23147649","article-title":"Mitf\/tfe translocation renal cell carcinomas: From clinical entities to molecular insights","volume":"23","author":"Simonaggio","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jasc.2026.02.003_bib38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/his.14731","article-title":"Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma","volume":"81","author":"Collins","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.jasc.2026.02.003_bib39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/PAS.0000000000001846","article-title":"Nf2-mutated renal carcinomas have common morphologic features which overlap with biphasic hyalinizing psammomatous renal cell carcinoma: A comprehensive study of 14 cases","volume":"46","author":"Paintal","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib40","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1093\/oncolo\/oyad040","article-title":"Comprehensive genomic profiling of nf2-mutated kidney tumors reveals potential targets for therapy","volume":"28","author":"Hacking","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.jasc.2026.02.003_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mrcc): A literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jasc.2026.02.003_bib42","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.5858\/2005-129-1017-DPAMCR","article-title":"Distinguishing primary and metastatic conventional renal cell carcinoma from other malignant neoplasms in fine-needle aspiration biopsy specimens","volume":"129","author":"Tabatabai","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"Suppl 8","key":"10.1016\/j.jasc.2026.02.003_bib43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/cncy.22029","article-title":"Ancillary studies in fine needle aspiration of the kidney","volume":"126","author":"Renshaw","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/cancers12010085","article-title":"Molecular genetics of renal cell tumors: A practical diagnostic approach","volume":"12","author":"Alaghehbandan","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jasc.2026.02.003_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/PAS.0000000000002357","article-title":"Pancreatic serous neoplasm and metastatic clear cell renal cell carcinoma: Diagnostic pitfalls resolvable by a panel of immunohistochemical stains to include pax8 and ck7 but not caix","volume":"49","author":"Theparee","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajmg.c.31410","article-title":"Swi\/snf chromatin remodeling complexes and cancer","volume":"166C","author":"Biegel","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.jasc.2026.02.003_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the swi\/snf complex gene pbrm1 in renal carcinoma","volume":"469","author":"Varela","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jasc.2026.02.003_bib48","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.aan5951","article-title":"Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma","volume":"359","author":"Miao","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jasc.2026.02.003_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.21037\/atm.2016.03.43","article-title":"Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis","volume":"4","author":"Modi","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jasc.2026.02.003_bib50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9440(10)64001-1","article-title":"Cdkna2a mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: Evidence for a second tumor suppressor gene proximal to cdkn2a","volume":"158","author":"Schraml","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humpath.2022.07.022","article-title":"The expanding role of bap1 in clear cell renal cell carcinoma","volume":"133","author":"Kapur","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jasc.2026.02.003_bib53","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.3892\/mmr.2014.3061","article-title":"Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein h1","volume":"11","author":"Liu","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jasc.2026.02.003_bib54","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.humpath.2013.03.009","article-title":"Nuclear expression of smad proteins and its prognostic significance in clear cell renal cell carcinoma","volume":"44","author":"Park","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2026.02.003_bib55","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00292-021-00985-y","article-title":"[smarcb1(ini1)-deficient renal cell carcinoma: Medullary and beyond: Evolving concepts]","volume":"42","author":"Agaimy","year":"2021","journal-title":"Pathologe"},{"key":"10.1016\/j.jasc.2026.02.003_bib56","article-title":"Fat3 mutation is associated with tumor mutation burden and poor prognosis in esophageal cancer","volume":"11","author":"Guo","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jasc.2026.02.003_bib57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eururo.2017.05.033","article-title":"Characterization of clinical cases of advanced papillary renal cell carcinoma via comprehensive genomic profiling","volume":"73","author":"Pal","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.jasc.2026.02.003_bib58","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/his.70069","article-title":"Papillary renal cell carcinoma, formerly known as type 2: A single institutional study addressing histologic and molecular features","volume":"88","author":"Tjota","year":"2025","journal-title":"Histopathology"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294526000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294526000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:01:17Z","timestamp":1779278477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294526000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213294526000256"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2026.02.003","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomorphologic and molecular characterization of metastatic renal cell carcinoma diagnosed by fine-needle biopsy: a single-institution study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Cytopathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}